期刊文献+

survivin在乳腺癌中的表达及其与Ki-67和c-erbB-2表达的关系 被引量:12

Expression of survivin in Breast Carcinoma and Its Relationgship with Ki-67 and c-erbB-2
下载PDF
导出
摘要 目的观察凋亡抑制蛋白survivin在乳腺癌组织中的表达,及其与c-erbB-2、Ki-67增殖指数的相关性及临床病理意义。方法应用免疫组织化学SP法检测survivin在正常乳腺组织(20例)和乳腺癌组织(96例)中的表达以及Ki-67、c-erbB-2在乳腺癌组织中的表达。结果 survivin阳性表达乳腺癌的Ki-67增殖指数(35.32±21.28)%明显高于survivin阴性者(20.42±11.34)%,survivin表达与肿瘤细胞增殖呈正相关(P<0.01);survivin在乳腺癌组织中的阳性表达率为70.83%(68/96),正常乳腺组织未见survivin表达;survivin蛋白的表达与c-erbB-2的表达呈正相关(P<0.01);sur-vivin蛋白的表达与临床分期、淋巴结转移和5年生存率有关(P<0.05),与年龄、是否绝经、肿瘤大小和组织学分级均无关。结论 survivin不仅参与凋亡的调控,还促进了细胞增殖,在乳腺癌发生、发展中起重要作用,过度表达提示预后不良。 Objective To study the expression of inhibitor apoptosis protein survivin in breast carcimoma and its correlation with,c-erbB-2 expression and cell proliferation index and its clinicopathological significance.[WTHZ]Methods Immunohistochemistry(SP method) was adopted to detect survivin protein in the tissues of normal mammary (20 cases),breast carcinoma (96 cases)and Ki-67,c-erbB-2 expressions in the breast carcinoma.Results The proliferation index in survivin-positive breast carcinoma (35.32±21.28)% was significantly higher than in survivin-negative breast carcinoma (20.42± 11.34 )% (P〈0.05),positive correlation between survivin expression and proliferative activity of tumor cell measured by Ki-67 index was found.The positive rate of survivin in breast carcinoma was 70.83%(61/96),but no expression of survivin was detected in normal mammary tissues.surivivin expression was positively correlated with c-erbB-2(P〈0.01).surivivin expression was related to clinic stage and lymph node metastasis and to 5 year survival rate.(P〈0.05),but not to age,menopause,tumor size and histological grade.Conclusion survivin is not only involved in control of apoptosis,but also accelerates proliferation.survivin gene may play an important role in tumorigenesis and progression of breast carcinoma.survivin over expression indicates worse prognosis and can be used to evaluate the prognosis as a potential index.
机构地区 解放军第 解放军第
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第7期773-776,共4页 Cancer Research on Prevention and Treatment
关键词 乳腺癌 SURVIVIN KI-67 C-ERBB-2 增殖指数 Breast carcinoma survivin Ki-67 c-erbB-2 Proliferation index
  • 相关文献

参考文献12

  • 1McCarthy EP, Ngo LH, Roetzheim RG, et al. Disparitiesin breast cancer treatment and survival for women with disabilities[J]. Ann Intern Med,2006,145(9): 637-645. 被引量:1
  • 2Yip KW, Shi W, Pintilie M, et al. Prognostic significance of the Epstein-Barr virus, p53, bcl-2, and survivin in nasopJaaryngeal cancer[J]. Clin Cancer Res, 2006, 12 (19):5726-5732. 被引量:1
  • 3Bowen AR, Hanks AN, Murphy KJ, et al. Proliferation, apoptosis and survivin expression in keratinoeytic neoplasms and hyperplasias[J]. Am J Dermatopathol,2004,26 (3) : 177-181. 被引量:1
  • 4Ahieri DC. survivin, versatile modulation of cell division and apoptosis in cancer[J]. Oneogene, 2003, 22 (53):8581-8589. 被引量:1
  • 5Span PN, Tjan HeijnenVC, Manders P, et al.'High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer[J]. Breast Cancer Res Treat, 2006,98 (2) : 223-230. 被引量:1
  • 6张晓雨,周建农,张彤.survivin、VEGF及Ki67在结直肠癌中的表达及其临床意义[J].肿瘤防治研究,2007,34(1):35-38. 被引量:18
  • 7Karabatsou K, Pal P, Dodd S, et al. Expression of survivin, platelet-derived growth factor A(PDGF A) and PDGF receptor alpha in primary central nervous system Iymphoma[J]. Neu rooncol, 2006,79(2) : 171-179. 被引量:1
  • 8毛杰,海健,舒衡平,唐利立,申正堂,邬玉辉,欧慧英.乳腺癌组织中survivin,p53蛋白的表达与预后的关系[J].中国普通外科杂志,2005,14(4):265-268. 被引量:25
  • 9Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation[J]. Int J Cancer, 1983,31 ( 1 ) : 13-20. 被引量:1
  • 10Bhatavdekar JM, Patel DD, Shah NG, et al. Prognostic significance of immunohistochemicallv localized biomarkers in stage II and stage III breast cancer: a multivariate analysis[J]. Ann Surg Oncol,2000,7(4) :305- 311. 被引量:1

二级参考文献6

共引文献42

同被引文献88

引证文献12

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部